Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.

Two hundred and eleven patients with node-positive stage II and III breast cancer were treated with eight cycles of adjuvant chemotherapy comprising cyclophosphamide, doxorubicin and oral ftorafur (CAFt), with and without tamoxifen. All patients had undergone radical surgery, and 148 patients were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Saarto, T., Blomqvist, C., Rissanen, P., Auvinen, A., Elomaa, I.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063283/
https://www.ncbi.nlm.nih.gov/pubmed/9010042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063283/
https://www.ncbi.nlm.nih.gov/pubmed/9010042

Ejemplares similares